The future treatment of patients will rely increasingly on multiple products which are working together to achieve an enhanced patient experience. Consequently, the regulatory framework which has historically been focused on individual product types (Medical Devices and Medicinal Products) needs to become more holistic. Simultaneously, while there is a focus on innovative precision agents, the combination with novel companion diagnostics creates significant impact and becomes an important point of collaboration between pharma and medical devices.

Who is This Track Designed For?

This track and associated sessions are designed for professionals involved, interested or curious about Medical Devices, Combination Products, Precision Medicine and Diagnostics.